The largest database of trusted experimental protocols

Anti hla dr bv570

Manufactured by BioLegend

Anti-HLA-DR BV570 is a fluorochrome-conjugated antibody that binds to the HLA-DR antigen, a major histocompatibility complex (MHC) class II cell surface receptor expressed on antigen-presenting cells. This product can be used for the identification and enumeration of HLA-DR-positive cells in flow cytometric analysis.

Automatically generated - may contain errors

2 protocols using anti hla dr bv570

1

HIV Interaction with Immune Synapses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Co-cultures were harvested 36 h after initiation, treated with 20 μg/ml of human IgG and stained with anti-HLA-DR BV570 (Clone L243, Biolegend) for 30 min at 4°C. Cells were then fixed with 2% methanol-free formaldehyde for 30 min, washed, and stained with phalloidin AF-647 in 0.3% saponin for 30 min at 4°C. At least 50,000 events were acquired for each sample and analyzed using the IDEAS Software version 5.0. To evaluate the HIV migration to the IS, we first quantified the iGFP-HIV intensity at the synapse divided by the total iGFP-HIV intensity. Second, we quantified the actin intensity at the interface divided by the total actin staining. Third, we plotted these two features to track the co-localization of HIV with polymerized actin at the IS. In some experiments, DCs were treated with Zidovudine (AZT, 1 μM) at the time of HIV infection to confirm HIV infection. In addition, cells were treated with Cytochalasin D (20 μM) or Nocodazole (100 μM) at the time of co-culture, as control of actin polymerization and viral movement.
+ Open protocol
+ Expand
2

Comprehensive Immunophenotyping of PBMC Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen PBMCs from human healthy donors were processed as for the HS1 datasset and stained with live/dead marker and fluorochrome-conjugated antibodies against the following surface markers: anti-CD8-BUV805, anti-CD4-BUV496, anti-CD95-BUV737, anti-CD28-BB660-P, anti-ICOS-BB630, anti-CXCR3-BV785, anti-PD-1-BV750-P, anti-CXCR5-BV650, anti-CCR2-BV605, (all BD Biosciences); anti-CD3-PerCP-Vio700 (Mil-tenyi Biotec); anti-CD45RA-FITC, anti-CD14-PE-Cy5.5, fixable viability dye eFluor780 (all eBioscience); anti-CD25-BV711, anti-CD31-BV480, anti-HLA-DR-BV570, anti-CD127-BV421, anti-CCR4-PE/Dazzle 594, anti-CCR7-PE-Cy7 (all BioLegend).
Samples were stained for 60 min at 4
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!